A P Kyritsis

436 total citations
11 papers, 394 citations indexed

About

A P Kyritsis is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, A P Kyritsis has authored 11 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in A P Kyritsis's work include Retinoids in leukemia and cellular processes (2 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). A P Kyritsis is often cited by papers focused on Retinoids in leukemia and cellular processes (2 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). A P Kyritsis collaborates with scholars based in United States, Greece and Japan. A P Kyritsis's co-authors include Victor A. Levin, J. M. Bruner, Melissa L. Bondy, Jin‐Myung Jung, Lauren A. Langford, Yukio Kobayashi, Sanbao Ruan, Wei Zhang, Mariza de Andrade and J Cunningham and has published in prestigious journals such as Neuro-Oncology, International Journal of Oncology and Oncology Reports.

In The Last Decade

A P Kyritsis

11 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A P Kyritsis United States 9 269 160 96 93 54 11 394
Grace Grant United States 5 176 0.7× 225 1.4× 68 0.7× 66 0.7× 128 2.4× 10 375
Jonas Ecker Germany 7 291 1.1× 232 1.4× 102 1.1× 95 1.0× 49 0.9× 11 488
Emma Arriola United Kingdom 7 276 1.0× 170 1.1× 55 0.6× 70 0.8× 79 1.5× 9 465
Giulia Orlando Italy 10 322 1.2× 121 0.8× 76 0.8× 47 0.5× 40 0.7× 30 484
Seiichiro Shimizu Japan 8 342 1.3× 124 0.8× 117 1.2× 29 0.3× 67 1.2× 12 439
Susan L. Marcelli United States 6 214 0.8× 120 0.8× 65 0.7× 172 1.8× 57 1.1× 7 346
Turgut Dogruluk United States 7 233 0.9× 104 0.7× 102 1.1× 39 0.4× 36 0.7× 8 369
Carlos R. Gil Del Alcazar United States 7 247 0.9× 205 1.3× 109 1.1× 91 1.0× 44 0.8× 9 440
Janet I. Lee United States 8 502 1.9× 191 1.2× 104 1.1× 32 0.3× 68 1.3× 8 636
Duk‐Hwan Kim South Korea 10 349 1.3× 109 0.7× 136 1.4× 88 0.9× 35 0.6× 10 503

Countries citing papers authored by A P Kyritsis

Since Specialization
Citations

This map shows the geographic impact of A P Kyritsis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A P Kyritsis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A P Kyritsis more than expected).

Fields of papers citing papers by A P Kyritsis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A P Kyritsis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A P Kyritsis. The network helps show where A P Kyritsis may publish in the future.

Co-authorship network of co-authors of A P Kyritsis

This figure shows the co-authorship network connecting the top 25 collaborators of A P Kyritsis. A scholar is included among the top collaborators of A P Kyritsis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A P Kyritsis. A P Kyritsis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mitlianga, Paraskevi, Chrissa Sioka, George Vartholomatos, et al.. (2006). p53 enhances the Δ-24 conditionally replicative adenovirus anti-glioma effect. Oncology Reports. 15(1). 149–53. 12 indexed citations
2.
3.
Puduvalli, Vinay K., Yuji Saito, Rui‐Hua Xu, et al.. (1999). Fenretinide activates caspases and induces apoptosis in gliomas.. PubMed. 5(8). 2230–5. 35 indexed citations
4.
Saitoh, Y., Takehiko Goto, Vinay K. Puduvalli, et al.. (1999). Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.. International Journal of Oncology. 15(3). 499–504. 9 indexed citations
5.
Trizna, Zoltán, Mariza de Andrade, A P Kyritsis, et al.. (1998). Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.. PubMed. 7(6). 553–5. 41 indexed citations
6.
Wei, Qingyi, Melissa L. Bondy, Li Mao, et al.. (1997). Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.. PubMed. 57(9). 1673–7. 50 indexed citations
7.
Bondy, Melissa L., A P Kyritsis, Jun Gu, et al.. (1996). Mutagen sensitivity and risk of gliomas: a case-control analysis.. PubMed. 56(7). 1484–6. 51 indexed citations
8.
Jung, Jin‐Myung, Hong Li, Tohru Kobayashi, et al.. (1995). Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.. PubMed. 6(8). 909–13. 13 indexed citations
9.
Fueyo, Juàn, Candelaria Gomez‐Manzano, W.K. Alfred Yung, et al.. (1995). A frequent polymorphism in exon 1 of thep16/CDKN2gene. Molecular and Cellular Probes. 9(6). 465–466. 1 indexed citations
10.
Jung, Jin‐Myung, J. M. Bruner, Sanbao Ruan, et al.. (1995). Increased levels of p21WAF1/Cip1 in human brain tumors.. PubMed. 11(10). 2021–8. 146 indexed citations
11.
Kyritsis, A P, Hideyuki Saya, & Victor A. Levin. (1993). MOLECULAR PATHOGENESIS AND MANAGEMENT OF GLIOMAS. Neuroimaging Clinics of North America. 3(4). 735–744. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026